By biopharmaapac.com
Publication Date: 2026-10-12 00:00:00
The initiative combines NVIDIA’s accelerated computing ecosystem with GenScript’s laboratory validation expertise, offering selected startups access to technical resources, investor engagement and a global pitching platform during JPM Week 2027.
GenScript Biotech Corporation announced the GenScript and NVIDIA Life Sciences Startup PitchFest, a global competition for startups applying artificial intelligence to therapeutic discovery and life sciences. The program brings together GenScript’s wet lab validation and data generation capabilities and NVIDIA’s accelerated computing platforms and startup ecosystem to help selected companies advance AI-driven platforms toward biological proof, investor engagement, and industry visibility.
Up to six finalists will be selected for a GenScript-hosted pitch event during JPM Week in January before a panel of judges. The winning company will receive GenScript wet lab data credits and Brev credits from NVIDIA to support its development efforts. Applications opened today, and finalists will be confirmed in December.
AI is making therapeutic discovery more expansive than ever, giving scientists new ways to generate hypotheses, identify targets, and design candidates at unprecedented speed. The PitchFest is designed to channel that momentum by connecting emerging AI drug discovery and life science companies with investors, technology leaders, and partners focused on turning computational…
